Failed Impurities/Degradation Specifications.
Teva North America
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
Class I - Dangerous
Superpotent drug: Out of specification test result for assay during stability testing.
Presence of Foreign Substance; presence of black particles describes generically as cellulose-based bundles of brown fibrous material.
Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.
Failed Tablet/Capsule Specifications
Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.
Lack of Assurance of Sterility: Due to potential for leaking bags.
Failed Dissolution Specifications: low test results at the 18 month time-point